EP1799269
Ólígóríbónúkeótíð og aðferðir við notkun þeirra í meðferð við skalla, bráðri nýrnabilun og öðrum sjúkdómum
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
27.9.2005EP published:
7.9.2016EP application number:
05788492.6
EP translation filed:
21.9.2016Grant published:
15.10.2016EPO information:
European Patent Register
Max expiry date:
26.9.2025Expiry date:
26.9.2022
Title:
OLIGORIBONUCLEOTIDES AND METHODS OF USE THEREOF FOR TREATMENT OF ALOPECIA, ACUTE RENAL FAILURE AND OTHER DISEASES
Timeline
Today
27.9.2005EP application
7.9.2016EP Publication
21.9.2016Translation submitted
15.10.2016Registration published
26.9.2022Expires
Owner
Name:
Quark Pharmaceuticals, Inc.Address:
6501 Dumbarton Circle, 94555, Fremont, CA, US
Inventor
Name:
FEINSTEIN, ElenaAddress:
Rehovot, IL
Name:
ZURR, DanielAddress:
Herzlia Pituach, IL
Name:
EHRLICH, ShaiAddress:
Walnut Creek, California CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
613991 PDate:
28.9.2004Country:
US
Number:
658196 PDate:
2.3.2005Country:
US
Number:
703020 PDate:
26.7.2005Country:
US
Classification
Categories:
C12N 15/113, A61K 31/713, C07H 21/02, A61P 13/12, A61P 17/14, A61P 25/00, A61P 27/16
Annual fees
Number
Paid
Expires
Payer
Number: 12
Paid: 11.10.2016
Expires: 26.9.2017
Payer: G. H. Sigurgeirsson
Number: 13
Paid: 21.8.2017
Expires: 26.9.2018
Payer: G. H. Sigurgeirsson
Number: 14
Paid: 22.8.2018
Expires: 26.9.2019
Payer: G. H. Sigurgeirsson
Number: 15
Paid: 21.8.2019
Expires: 26.9.2020
Payer: G. H. Sigurgeirsson
Number: 16
Paid: 10.9.2020
Expires: 26.9.2021
Payer: G.H. Sigurgeirsson ehf.
Number: 17
Paid: 10.9.2021
Expires: 26.9.2022
Payer: G.H. Sigurgeirsson ehf.